Literature DB >> 23713799

Determinants of physicians' prescribing behaviour of methylphenidate for cognitive enhancement.

Koen Ponnet1, Edwin Wouters, Guido Van Hal, Wannes Heirman, Michel Walrave.   

Abstract

The non-medical use of methylphenidate for cognitive enhancement becomes a more and more common practice among college and university students. Although physicians are a source of access, little is known about the underlying mechanisms that might lead to physicians' intention and behaviour of prescribing methylphenidate to improve students' academic performance. Applying Ajzen's theory of planned behaviour (TPB), we tested whether attitudes, subjective norms (controllability and self-efficacy) and perceived behavioural control predicted the intention and the prescribing behaviour of physicians. Participants were 130 physicians (62.3% males). Structural equation modelling was used to test the ability of TPB to predict physicians' behaviour. Overall, the present study provides support for the TPB in predicting physicians' prescribing behaviour of methylphenidate for cognitive enhancement. Subjective norms, followed by attitudes, are the strongest predictors of physicians' intention to prescribe methylphenidate. To a lesser extent, controllability predicts the intention of physicians, and self-efficacy predicts the self-reported behaviour. Compared to their male colleagues, female physicians seem to have more negative attitudes towards prescribing methylphenidate for cognitive enhancement, feel less social pressure and perceive more control over their behaviour. Intervention programmes that want to decrease physicians' intention to prescribe methylphenidate for improving academic performance should primarily focus on alleviating the perceived social pressure to prescribe methylphenidate and on converting physician neutral or positive attitudes towards prescribing methylphenidate into negative attitudes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23713799     DOI: 10.1080/13548506.2013.802361

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  4 in total

1.  Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.

Authors:  Andreas G Franke; Carolin Papenburg; Elena Schotten; Peter B Reiner; Klaus Lieb
Journal:  BMC Fam Pract       Date:  2014-01-08       Impact factor: 2.497

2.  Models and theories of prescribing decisions: A review and suggested a new model.

Authors:  Mohsen Ali Murshid; Zurina Mohaidin
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

3.  Use and misuse of prescription stimulants by university students: a cross-sectional survey in the french-speaking community of Belgium, 2018.

Authors:  Martine Sabbe; Javier Sawchik; Mégane Gräfe; Françoise Wuillaume; Sara De Bruyn; Pierre Van Antwerpen; Guido Van Hal; Martin Desseilles; Jamila Hamdani; Hugues Malonne
Journal:  Arch Public Health       Date:  2022-02-16

4.  Use of neuroenhancement drugs: prevalence, frequency and use expectations in Switzerland.

Authors:  Stéphane Deline; Stéphanie Baggio; Joseph Studer; Alexandra A N'Goran; Marc Dupuis; Yves Henchoz; Meichun Mohler-Kuo; Jean-Bernard Daeppen; Gerhard Gmel
Journal:  Int J Environ Res Public Health       Date:  2014-03-12       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.